why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: April 02, 2025

Clinical Trial: A Phase 2a Study of LLX-424 in Patients With a History of Kidney Stones

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Kidney Stones

Study Type: INTERVENTIONAL


Official Title: A Phase 2a Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamic (PD) Effects of LLX-424 in Patients With a History of Kidney Stone

Brief Summary: This is a Phase 2a study of glycolate oxidase inhibitor LLX-424 in patients with a history of kidney stones.Eligible subjects with a history of kidney stones will be randomized to receive study drug (LLX-424 or placebo) for 8 weeks.

Read more